Interleukin-1 1 (IL-11) is a newly identified lymphohematopoietic cytokine originally derived from the primate bone marrow stromal cell line, PU-34. Separately, we reported that IL-1 1 augments IL-l-dependent proliferation of primitive murine hematopoietic progenitors in culture. We have now examined the synergistic interactions between IL-11 and IL-4 in support of colony formation from marrow cells of mice treated 2 days before with 150 mg/kg 5-fluorouracil. Neither recombinant human IL-11 nor murine IL-4 alone was effective in the support of colony formation. When the two factors T IS GENERALLY HELD that in steady-state bone I marrow, hematopoietic stem cells reside in a quiescent state termed Go and divide only infrequently to yield actively proliferating multipotential progenitors. Recent progress in the molecular and cellular biology of hematopoietic stem cells has shown that several factors are involved in the initiation of cell cycling of dormant stem cells. In our laboratory, we have observed that interleukin-3 (IL-3)' and IL-42 support proliferation of early murine multipotential progenitors, but that these factors do not trigger the dormant progenitors into cell proliferation. We proposed that these factors provide a permissive milieu for the proliferation of progenitors only after they exit from Go. We subsequently showed that IL-6' and granulocyte colonystimulating factor (G-CSF)4 act synergistically with IL-3 by shortening the Go period in which the primitive progenitors reside.
T IS GENERALLY HELD that in steady-state bone I marrow, hematopoietic stem cells reside in a quiescent state termed Go and divide only infrequently to yield actively proliferating multipotential progenitors. Recent progress in the molecular and cellular biology of hematopoietic stem cells has shown that several factors are involved in the initiation of cell cycling of dormant stem cells. In our laboratory, we have observed that interleukin-3 (IL-3)' and IL-42 support proliferation of early murine multipotential progenitors, but that these factors do not trigger the dormant progenitors into cell proliferation. We proposed that these factors provide a permissive milieu for the proliferation of progenitors only after they exit from Go. We subsequently showed that IL-6' and granulocyte colonystimulating factor (G-CSF)4 act synergistically with IL-3 by shortening the Go period in which the primitive progenitors reside.
Recently, a novel lymphohemopoietic cytokine (IL-11) was identified in medium conditioned by a cell line that had been derived from the primate bone marrow stromal cell line, PU-34. 5 We have found that recombinant IL-11 enhances IL-3-dependent colony formation from spleen and marrow cells of mice injected with 150 mg/kg 5-fluorouracil (5-FU).6 Serial observations (mapping) of cultures of post-5-FU spleen cells indicated that the mechanism of the IL-11 augmentation is to shorten the dormant period in which stem cells reside,6 an effect very similar to that of IL-6 and G-CSF. We have now extended our studies to include synergistic interactions between IL-11 and IL-4 on the proliferation of early hematopoietic progenitors, and have found similar synergy between IL-11 and IL-4 in the initiation of proliferation of dormant progenitors.
MATERIALS AND METHODS
Cell preparation. Ten-to 15-week-old female BDF, mice were obtained from ARS Sprague Dawley (Indianapolis, IN). Single cell suspensions were prepared from pooled femurs of three mice. 5-FU (Adria Laboratories, Columbus, OH) was administered intravenously (IV) through the tail veins of mice at 150 mg/kg body weight."' Bone marrow were harvested from three mice 2 days after 5-FU injection.
Human IL-11 was purified partially from medium conditioned by COS-1 cells that had been transfected with cDNA encoding human IL-11: This material was 30% pure with a specific activity of 2.5 x lo' Ulmg protein by the T1165 proliferation assay?
The source of recombinant murine IL-3 was medium conditioned by Chinese hamster ovary (CHO) cells that had been genetically engineered to produce murine IL-3 to high titer (approximately 30,000 UlmL). Recombinant murine IL-4 expressed in yeast was purified to homogeneity by ion-exchange chromatography on S-Sepharose followed by reverse-phase high performance liquid chromatography (HPLC) similar to the method described previously.' Purified IL-4 had a specific activity of 1 x lo8 U/mg protein by an anti-IgM costimulation assay.'" Purified recombinant human erythropoietin (Epo) with a specific activity of 1.2 X 10' Uimg protein was provided by Drs R. Steinbrink and P. Schendl (Genetics Institute, Cambridge, MA).
Methylcellulose cell culture was performed in 35-mm Lux suspension culture dishes (no. 5221R; Nunc, Inc, Naperville, IL). One milliliter of culture contained 5 x 10s spleen cells or 2 x lo4 marrow cells from normal mice or 1 x IO6 spleen cells or 5 x lo4 marrow cells from 5-FU-treated mice, a-medium (Flow Laboratories, Inc, McLean, VA), 1.2% 1,500 cps methylcellulose (Fisher Scientific Co, Norcross, GA), 30% fetal calf serum (FCS; Hyclone Laboratories, Inc, Logan, UT), 1% deionized fraction V bovine serum albumin (Sigma Chemical Co, St Louis, MO), 1 x mol/L 2-mercaptoethanol (Eastman Organic Chemicals, Rochester, NY), and hematopoietic factors. Dishes were incubated at 37°C in a humidified atmosphere flushed with 5% CO,, and colonies consisting of 50 or more cells were scored on an inverted microscope on the specified day of incubation.
Factors.
Clonal cell culture. Post-5-FU marrow cells (5 x IO') were plated per dish and colonies were scored on day 16. Data represent numbers of total colonies in four dishes.
RESULTS

Colony formation
Abbreviations: Mast, mast cell colonies; GMM, granulocytelmacrophage/megakaryocyte colonies; BI, blast cell colonies. macrophage (GM) and multilineage colonies. When these factors were combined, there was major enhancement of total colony formation as well as multilineage colony formation. In this experiment, the enhancement by IL-11 of IL-3-dependent colony formation was similar to our previous observations.6 The types of colonies supported by these factors individually and in combinations are presented in Table 1 . Combination of IL-11 with IL-3 or IL-4 increased not only the GM colonies but also the granulocyte/ erythrocyte/macrophage/megakaryocyte (GEMM) colonies. growth rates of individual blast cell colonies through colony mapping studies. The results are presented in Fig 2. Fifty thousand day-2 post-5-FU marrow cells were plated per dish in the presence of 2 U/mL Epo and either IL-11 alone (Fig 2A) or a combination of IL-11 and IL-4 (Fig 2C) , and the emergence of new blast cell colonies and their subsequent rates of proliferation were analyzed. As controls, aliquots of the same sample were plated in the presence of IL-3 alone (Fig 2B) or a combination of IL-3 and IL-11 ( Fig  2D) . IL-4 alone failed to support multipotential blast cell colonies. IL-11 alone also supported formation of only a few blast cell colonies and, therefore, colony formation shown in Fig 2A is from a total of four dishes. While in cultures containing IL-11 alone multipotential blast cell colonies emerged after varying time intervals, the combinations of IL-11 and IL-4 hastened the development of blast cell colonies and gave more colonies. Similar to our previous observations,6 blast cell colony formation was augmented and hastened by the combination of IL-11 and IL-3 ( Fig 2D) compared with IL-3 alone (Fig 2B) . Information on the kinetic parameters of the blast cell colonies is summarized in Table 2 . The doubling times of individual blast cell colonies under the four different culture conditions did not differ significantly while the average number of days required for colonies to reach 100 cells was significantly smaller in cultures containing combinations of three factors than in the cultures containing either Epo plus IL-11 or Epo plus IL-3. Extrapolation of the log linear growth of blast cell colonies to one cell stage (Table 2) indicates that first cell division of the progenitors took place 7 days after cell plating in cultures containing Epo and IL-11 and 2 days after cell plating in cultures containing Epo, IL-4, and IL-11. These observations indicate that the synergism between IL-11 and IL-4 may be due partly to shortening the Go period in which early progenitors reside.
Serial observations of blast cell colony development from
DISCUSSION
IL-4 was originally identified as one of the T-cell products that mediates anti-IgM-induced DNA synthesis in B cells.'" Independently, IL-4 was identified as a mast cell growth factor that is distinct from IL-3." Subsequently, murine IL-4 was shown to have significant effects on hematopoietic proliferation by several investigators. Hamaguchi et all2 described that murine IL-4 is essential for the proliferation of connective tissue-type mast cells. Peschel et al" reported that IL-4, in the presence of G-CSF, enhances proliferation of GM progenitors and, in the presence of Epo, stimulates proliferation of erythroid and multipotential progenitors. The synergistic ability of IL-4 was also documented by Rennick et all4 and Broxmeyer et al." In our laboratory we have observed that IL-4, like IL-3, supports blast cell colony formation from normal mice and works synergistically with IL-6 in the proliferation of primitive hematopoietic progenitors?
In this report, we have shown that IL-4 also interacts with IL-11 to stimulate proliferation of dormant hematopoietic progenitors. While IL-4 and IL-11 individually supported only scant colony formation from day-2 post-5-FU marrow cells, the combination of the two factors showed major enhancement of colony formation. In addition, this combination significantly hastened the emergence of multipotential blast cell colonies. Currently, several hematopoietic growth factors and their combinations are being tested in patients with a variety of hematopoietic disorders for stimulation of hematopoietic proliferation. There are a number of clinical situations in which active cell divisions of dormant hematopoietic stem cells may lead to facile restoration of hematopoiesis and hence optimal recovery of the patients. The synergistic interactions of IL-4 and IL-11 that we observed in culture may indicate a potential use of the combination of the two factors in vivo. Studies are underway to examine the effects of combinations of human IL-4 and human IL-11 on human hematopoietic progenitors.
